Why Is This Important?
Homeopathy has been a polarizing medicine since its inception over 200 years ago by Samuel Hahnemann. Conventional medicine has been fighting homeopathy ever since, particularly in times when it was much more popular than allopathy.Homeopathic medicines are cheap to produce, can’t be patented, and are easy to replicate, thus it is seemingly impossible to achieve the staggering profit levels from homeopathic medicines that pharmaceutical companies are accustomed to earning today. Hence, the industrial medical complex sees homeopathy as a threat to its profits and continued existence. I would like to assert otherwise, that homeopathy, conventional medicine and other forms of traditional medicine can all co-inhabit the same space and enrich each other’s effectiveness in the real world, but that is a topic for another article.
We have moved into an era where evidence-based medicine is considered the gold standard. But how can we move forward in health policy and appropriate treatments when the “evidence base” itself is biased, fraudulent and influenced by profits? While funding for research in Natural Medicine is almost non-existent.
What Is Wrong With the NHMRC Review?
The review claims to have looked at 1800 studies, but in fact they only considered 176, of which only 5 matched their unprecedented quality thresholds, based on the number of participants in a study. They only looked at studies that had more than 150 participants. While this may sound reasonable at first, it in fact has nothing to do with the NHMRC’s standards for other trials, and this minimum set sample size has never been used before, or since, as it has no scientific basis[iii]. Other NHMRC-published evidence reviews have no minimum trial size for reliability. The British Medical Journal (BMJ), one of the most highly respected journals in the world, sets their minimum for quality at 20 participants. Add to this the fact that this arbitrary number was decided upon in a posthoc analysis, the accusation of bias is hard to dismiss. .[iv] You can read more about it online.Fraud
When the Australian Homeopathic Association (AHA) learned of this report, they made a Freedom of Information Request to get a better understanding of what had happened with this study. What they uncovered was simply unbelievable - there had been, in fact, a previous review, also commissioned by the NHMRC. This second review had been buried! What could the implication be, you ask?What Was Found in the First Report?
The first report concluded that there is encouraging evidence for homeopathy in 5 conditions: fibromyalgia, ear infections, upper respiratory tract infections, side effects of cancer treatment, and postoperative ileus (first time to flatus after surgery). I want to clarify that this doesn’t mean that the evidence was negative in other areas, only that there weren’t enough high-quality trials to make a proper assessment.This is not absolute proof that homeopathy works, but it is a far cry from the notion that there is no evidence in its favor. The truth of the matter is that we need to do more research, but funding for this kind of work is extremely limited. Even though excellent research is slowly trickling out, we still have a long way to go, and scientists have a hard time building a career while focusing on alternative medicine. And, the NHMRC report, released in 2015, only made matters worse. Such a negative message in the public eye led to even less funding being available for new homeopathic studies.
The First Report is in draft form and as such it is not a ‘perfect' finalized document. However, the report was sufficiently well-formed to have undergone peer review. FOI requests revealed that a member of NHMRC’s committee overseeing the review process considered the first review to be high quality saying, “I am impressed by the rigor, thoroughness and systematic approach given to this evaluation [….] Overall, a lot of excellent work has gone into this review and the results are presented in a systematic, unbiased and convincing manner.”4 (Professor Fred Mendelsohn, NHMRC Homeopathy Working Committee).[x]To rub salt in the wound, NHMRC released the report with annotations from their CEO, Professor Anne Kelso. The notes insinuate that this review is of low quality (very much in opposition to the panel’s previous comments on the review). The Author, Dr. Grimmer, was never given the opportunity to respond to these notes before the release of the report.
“This gives the impression that Prof Grimmer has not given sufficient consideration to the quality of the evidence being reviewed - a remarkable claim given her expertise and experience in using the FORM approach. In fact, risk of bias is one of the factors the author would have considered when assigning a ‘grade' to the evidence base for each medical condition (grading it from A-D). Risk of bias is therefore integrated within the report’s findings throughout, as well as being presented directly in the main text of each chapter.”[xi]Just to reiterate, Dr. Grimmer is considered a foremost expert in the FORM approach[xii] the framework that the Australian government has adopted for guideline development, it is misleading to assume her work is of inferior quality, these comments represent a petty attempt to discredit the report and save face.